Leveraging CIRM Infrastructure to Improve Accessibility Panel - From left to right: Noah Federman, MD (moderator), Catriona Jamieson, MD, PhD, Mehrdad Abedi, MD, Daniela Bota, MD, PhD, Thomas Buchanan, MD, Brian Fury, MS, Dhruv Sareen, PhD, and Taby Ahsan, PhD The California Institute for Regenerative Medicine (CIRM) recently sponsored the 7th Annual CIRM Alpha Clinics … Continue reading CIRM Showcases Strategic Vision and New Initiatives at 7th Annual Alpha Clinics Network Symposium
News
ICYMI – From Undergratuate to Hero: Solano Student’s Life-Saving Bone Marrow Match Begins with One Swab
Image Source: Jose Solorio At the California Institute for Regenerative Medicine (CIRM), we believe stem cells have the potential to change lives. Jose Solorio, a Solano Community College student and participant in CIRM’s COMPASS training program, has firsthand experience in witnessing the power of stem cells as a donor. As part of CIRM's COMPASS program, … Continue reading ICYMI – From Undergratuate to Hero: Solano Student’s Life-Saving Bone Marrow Match Begins with One Swab
CIRM Recommendations from Strategic Allocation Framework
The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutes dedicated to regenerative medicine, announced key recommendations at the September 26, 2024, Independent Citizens’ Oversight Committee Meeting from its Strategic Allocation Framework (SAF), a structured and data-driven effort designed to prioritize resources and maximize the impact of CIRM’s funding. These recommendations mark … Continue reading CIRM Recommendations from Strategic Allocation Framework
Inaugural UC San Diego Gene Therapy Initiative Symposium is fueling progress in the field
There was no shortage of enthusiasm at the inaugural UC San Diego Gene Therapy Initiative Symposium hosted at the Roth Auditorium at the prestigious Sanford Consortium, where researchers, clinicians, academia, industry, and patient advocates shared discoveries in gene therapy, a modern-day treatment that’s revolutionizing medicine.CIRM was a platinum sponsor of the event.The gene therapy field … Continue reading Inaugural UC San Diego Gene Therapy Initiative Symposium is fueling progress in the field
From Undergraduate to Hero: Solano Student’s Life-Saving Bone Marrow Match Begins with One Swab
SCC student and CIRM trainee Jose Solorio donated bone marrow to save an 11-year-old patient's life in New York. In a remarkable display of compassion and scientific collaboration, Solano Community College (SCC) student Jose Solorio, a scholar in the college's biomanufacturing bachelor's program, has become a real-life hero. Through Solano’s partnership with the National Marrow … Continue reading From Undergraduate to Hero: Solano Student’s Life-Saving Bone Marrow Match Begins with One Swab
CIRM awards $8 million to Support Groundbreaking Gene Therapy for AML and MDS
Image source: Canva Around 20,000 Americans are affected by acute myeloid leukemia (AML) each year. AML is a type of cancer that originates in the bone marrow and rapidly enters the bloodstream. Additionally, many individuals are impacted by myelodysplastic syndromes (MDS), which are blood disorders that result in the improper formation or functioning of blood … Continue reading CIRM awards $8 million to Support Groundbreaking Gene Therapy for AML and MDS
How the Strategic Allocation Framework (SAF) Impacts the Future of CIRM’s Research Funding
At the California Institute for Regenerative Medicine (CIRM), our mission is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world. For nearly two decades, CIRM has been at the forefront of the regenerative medicine field, catalyzing significant scientific breakthroughs and developing therapies that … Continue reading How the Strategic Allocation Framework (SAF) Impacts the Future of CIRM’s Research Funding
CIRM $4 million awarded to support innovative Gene Therapy for Rare Heart Disorder
Image Source: American Heart Association Journals The California Institute for Regenerative Medicine (CIRM) recently awarded $4 million to support the development of a one-time gene therapy for desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM), a rare and life-threatening genetic disorder. This preclinical award to Deborah D. Ascheim, MD, and her team at Rejuvenate Bio are … Continue reading CIRM $4 million awarded to support innovative Gene Therapy for Rare Heart Disorder
CIRM awards $26 million to boost clinical trials for cancer, heart, and rare diseases
The California Institute for Regenerative Medicine (CIRM) is proud to announce the allocation of $26 million to support clinical research targeting a range of cancers, heart conditions, and rare diseases. This significant funding underscores CIRM’s commitment to advancing innovative stem cell and gene therapy-based treatments through all stages of clinical trial development. This latest round … Continue reading CIRM awards $26 million to boost clinical trials for cancer, heart, and rare diseases
Meet Our New CEO: Jonathan Thomas
We are thrilled to (re)introduce Jonathan Thomas (JT) as the new President and CEO of the California Institute for Regenerative Medicine (CIRM). You can check out the original press release here. We recently sat down with JT –who previously served as Chair of the Independent Citizens’ Oversight Committee (ICOC) as well as interim President and … Continue reading Meet Our New CEO: Jonathan Thomas
The Stem Cellar 